Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT06902558 is registered in ClinicalTrials.gov with Calico Life Sciences LLC as lead sponsor.

NCT NCT06902558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06902558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Lead sponsor
Calico Life Sciences LLC
Phase
Phase 2
Overall status
Recruiting
Start date
June 9, 2025
Completion date
August 31, 2029
Enrollment
240 (estimated)
Sites
91

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant polycystic kidney disease